| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/10/2008 | US20080166329 Medical device and methods for living cell injection |
| 07/10/2008 | US20080166327 Expanding hemangioblast in serum-free culture medium containingstem cell factor, interleukin-6, tyrosine kinase and thrombopoietin and recovering multipotent stem cells for use in treatment of ischemic cardiac disorders; tissue engineering; regenerative medicine |
| 07/10/2008 | US20080166320 Using benzoquinone antibiotic producing streptomyces as biocontrol tool in treatment plant diseases |
| 07/10/2008 | US20080166300 Screening for agents that modulate a cancer associated phosphatase function; combining a candidate biologically active agent with a polypeptide having phosphatase activity; assessing the effectiveness on cancer cells |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 07/10/2008 | DE102007002073A1 Medium for use during care and antimicrobial treatment of skin, for topical dermatological application, and for therapeutic skin and sore treatment, comprises benzalkonium chloride, which is basically exclusive pharmaceutically active |
| 07/10/2008 | CA2674550A1 Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
| 07/10/2008 | CA2674144A1 Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
| 07/10/2008 | CA2673965A1 Pyrazolopyrimidine compound |
| 07/10/2008 | CA2668738A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942113A1 Neuronal differentiation inhibitor peptide and use thereof |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1942105A1 Aminodihydrothiazine derivative |
| 07/09/2008 | EP1942101A1 Secretase inhibitor |
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941899A1 Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level |
| 07/09/2008 | EP1941890A1 Hematopoietic stem cell proliferator |
| 07/09/2008 | EP1941876A1 Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension |
| 07/09/2008 | EP1941873A1 Metallo-beta-lactamase inhibitor |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1941867A1 Prevention and reduction of blood loss |
| 07/09/2008 | EP1940788A1 1-benzylindole-2-carboxamide derivatives |
| 07/09/2008 | EP1940402A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/09/2008 | EP1940379A2 Methods for treatment of hemorrhagic shock and related disorders |
| 07/09/2008 | EP1653957B1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 07/09/2008 | EP1570839B1 Composition for preparation for external use on skin and method of using the same |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 07/09/2008 | EP1408109B1 Novel method for the induction of cellular senescence and method for screening anti-aging agent |
| 07/09/2008 | EP1379496B1 Sulphones which modulate the action of gamma secretase |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1286674B1 Composition for potentiating cancer chemotherapeutic agents |
| 07/09/2008 | EP1234185B1 Pin1 as a marker of the stage of agressiveness and/or metastasis of abnormal cell growth |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 07/09/2008 | EP0959878B1 Method for treating renal failure |
| 07/09/2008 | EP0932674B1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES |
| 07/09/2008 | CN101217952A Composition for preventing occurrence of cardiovascular event |
| 07/09/2008 | CN101214259A Pilose antler basic fibroblast growth factor (DEER FGF) extraction and preparation thereof |
| 07/09/2008 | CN101214249A Chaperone-based therapy for niemann-pick disease |
| 07/09/2008 | CN101214248A Triazolo[4,5-d] pyrimidine derivatives and their application as purinergic receptor antagonists |
| 07/09/2008 | CN101213953A Method for breeding chick |
| 07/09/2008 | CN101213952A Method for producing low cholesterol egg without residual agricultural chemical |
| 07/09/2008 | CN100400659C Component of bromelain |
| 07/09/2008 | CN100400548C Fusional protein with intensified activity of internal red-blood-cell formation element |
| 07/09/2008 | CN100400535C Adiponectin expression promoter |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400103C Pharmaceutical composition |
| 07/09/2008 | CN100400060C Health protection medicine for anti fatigue |
| 07/09/2008 | CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/09/2008 | CN100399928C Preparation method of yellow gumbo freeze dried powder |
| 07/08/2008 | US7396946 Compound for treatment of external secretion disorders |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396911 Preventing, treating, or ameliorating human immunodeficiency virus infection |
| 07/08/2008 | US7396858 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
| 07/08/2008 | US7396837 topoisomerase I inhibitors; stimulate topoisomerase I-mediated DNA cleavage and their cytotoxic potential; antitumor agent; prostate gland, ovaries, colon cancer; marine alkaloids |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396832 Inhibitors of Akt activity |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 07/08/2008 | US7396818 Sulfotransferase inhibitor |
| 07/08/2008 | US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
| 07/08/2008 | US7396681 Inducing an immune response by natural killer cells to increase cytolytic activity or stimulate cell proliferation by administering in or ex vivo a specific chaperone protein; treating cancerous, infectious and autoimmune diseases |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396652 Chemokine PANEC-2 polypeptides and compositions and methods related thereto |
| 07/08/2008 | US7396643 Screening sample for the presence of transcription factors; obtain nucleotide sequences, join to solid support, incubate with transcription factors, detect signal |
| 07/08/2008 | US7396529 Compositions and methods for regulating receptor clustering |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2420177C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/08/2008 | CA2372377C A novel inhibitor of beta amyloid cleavage enzyme |
| 07/08/2008 | CA2368775C Treatment of cardiovascular and related pathologies |
| 07/08/2008 | CA2360754C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 07/08/2008 | CA2333154C Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 07/08/2008 | CA2330719C Synergistic compositions comprising an ascorbate and lysine for states related to extra cellular matrix degeneration |
| 07/08/2008 | CA2304947C Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 07/08/2008 | CA2298681C Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 07/08/2008 | CA2211939C Process for producing rhein and diacerhein |
| 07/08/2008 | CA2203961C Storage-stable fibrinogen preparations |
| 07/08/2008 | CA2162587C Therapeutic inhibitor of vascular smooth muscle cells |
| 07/08/2008 | CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/08/2008 | CA2117782C Use of renin-angiotensin antagonist for reducing post myocardial infarct morbidity and mortality |
| 07/03/2008 | WO2008080128A1 Devices and methods for inhibiting fibrosis |